DavidAHornbackMD

Radiation Oncology • South Bend, IN

Medical Director

Join to view full profile

Dr. Hornback is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Hornback's full profile

Already have an account?

Office
621 Memorial Dr
Ste 100
South Bend, IN 46601
Phone+1 574-647-1100

Fax+1 574-647-3148

Education & Training

Indiana University School of MedicineResidency, Radiation Oncology, 1989 - 1992
Ascension St Vincent Hospital IndianapolisInternship, Transitional Year, 1988 - 1989
Indiana University School of MedicineClass of 1988

Certifications & Licensure

CA State Medical License 2012 - Present
IN State Medical License 1989 - 2025
MI State Medical License 1990 - 2019
American Board of Radiology Radiation Oncology

Clinical Trials

Radiation Therapy (WBI Versus PBI) in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer Start of enrollment: 2005 Mar 01
Completed
Not Applicable
Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer
ACTIVE_NOT_RECRUITING
PHASE3
Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma Start of enrollment: 2009 Apr 15
Completed
Phase 3
Chemotherapy and Pelvic Radiation Therapy With or Without Additional Chemotherapy in Treating Patients With High-Risk Early-Stage Cervical Cancer After Radical Hysterectomy
ACTIVE_NOT_RECRUITING
PHASE3
Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer Start of enrollment: 2011 Feb 14
Completed
Phase 3
Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer
ACTIVE_NOT_RECRUITING
PHASE3
Higher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery Start of enrollment: 2011 May 24
ACTIVE_NOT_RECRUITING
PHASE3
Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma Start of enrollment: 2012 Dec 20
Completed
Phase 2
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer Start of enrollment: 2013 Mar 22
RECRUITING
PHASE2, PHASE3
Join now to see all

Publications & Presentations

PubMed

95 citations
Phase II Randomized Trial of Two Nonoperative Regimens of Induction Chemotherapy Followed by Chemoradiation in Patients With Localized Carcinoma of the Esophagus: RTOG...
Jaffer A. Ajani, Kathryn Winter, Ritsuko Komaki, D. P. Kelsen, Bruce D. Minsky
Journal of Clinical Oncology. 2008-10-01
10 citations
Dual 24-hour feeding response to 2DG in rats: Daytime increase and nighttime decrease
Carl I. Thompson, Robert L. Fleming, Kenneth A. Franken, David A. Hornback, Steven P. Boha
Physiology & Behavior. 1989-01-01